基于网络药理学探讨玫瑰花抗抑郁物质基础及作用机制

doi:10.3976/j.issn.1002-4026.2022.04.006

Abstract

Abstract:

To explore the active ingredients and mechanism of Rosae Rugosae Flos for antidepressant activity by network pharmacology and the molecular docking method. This study collected the antidepressant monomers and chemical components of Rosae Rugosae Flos by searching the China National Knowledge Infrastructure database, predicted the antidepressant active ingredients and targets with the aid of the PubChem and SwissTargetPrediction databases, performed pathway enrichment analysis through the Database for Annotation, Visualization and Integrated Discovery, and used Discovery Studio 2017 software to perform molecular docking. A total of 117 antidepressant monomers and 127 Rosae Rugosae Flos ingredients were collected. Furthremore, 17 antidepressant-related core components were screened out from Rosae Rugosae Flos. The molecular docking showed that Rosae Rugosae Flos contains six active ingredients, which are apigenin, quercetin, kaempferol, isoeugenol, isoquercitrin, and cyanidin 3-O-glucoside that can bind to the three depression-related targets AKT1, PTGS2, and ESR1. The results indicated that the antidepressant material basis of Rosae Rugosae Flos is flavonoids, such as apigenin, quercetin, kaempferol, and so on, which mainly affect the neuroactive ligand -receptor interaction and the HIF-1, prolactin, and dopaminergic synaptic signaling pathways, which play an antidepressant role. The research will be expected to offer new ideas for the next steps in studying Rosae Rugosae Flos for any evidence of new antidepressant drug discoveries.

Key words: Rosae Rugosae Flos, depression, network pharmacology, molecular docking

CLC Number:

R285.5

LIANG Meng-meng, SHAO Xin-xin, CHEN Cong, ZHANG Song, ZHANG Guang-zhong, LI Jia. The basis and mechanism of Rosae Rugosae Flos antidepressants based on network pharmacology[J].Shandong Science, 2022, 35(4): 38-48.

Figures/Tables 13

Fig.1

Table 1

Fig.2

Fig.3

Fig.4

Fig.5

Fig.6

Fig.7

Fig.8

Table 2

Fig.9

Fig.10

Fig.11

References 27

[1]	黄颖林, 孟祥伟, 张珍珍, 等. 认知功能对抑郁症住院患者治疗反应的预测[J]. 中国医科大学学报, 2021, 50(5):439-443. DOI: 10.12007/j.issn.0258-4646.2021.05.011. doi: 10.12007/j.issn.0258-4646.2021.05.011
[2]	World Health Organization. Depression and other common mental disorders[EB/OL].[2021-09-17]. .
[3]	唐梅, 李向平. 抗抑郁药的不良反应及其在心血管病患者中的应用[J]. 中南大学学报(医学版), 2020, 45(10):1228-1233. DOI: 10.11817/j.issn.1672-7347.2020.190160. doi: 10.11817/j.issn.1672-7347.2020.190160
[4]	程瑶. 小柴胡汤对抑郁症病人脑源性神经营养因子、睡眠质量及神经功能相关因子的影响[J]. 中西医结合心脑血管病杂志, 2017, 15(10):1250-1252.
[5]	国家药典委员会. 中华人民共和国药典2020年版一部[M]. 北京: 中国医药科技出版社, 2020:209.
[6]	吕俊涛, 李洒洒, 王宇, 等. 玫瑰花多糖提取纯化、理化性质及生物活性研究进展[J]. 牡丹江医学院学报, 2018, 39(4):118-119. DOI: 10.13799/j.cnki.mdjyxyxb.2018.04.040. doi: 10.13799/j.cnki.mdjyxyxb.2018.04.040
[7]	梁明坤, 韦宇婷, 梁杏秋, 等. 玫瑰花颗粒对抑郁小鼠行为学及血清5-HT的影响[J]. 陕西科技大学学报, 2021, 39(1):70-74. DOI: 10.19481/j.cnki.issn2096-398x.2021.01.012. doi: 10.19481/j.cnki.issn2096-398x.2021.01.012
[8]	王梦瑜, 邵欣欣, 李谨彤, 等. 中药抗菌活性分布规律及影响因素挖掘研究[J]. 天然产物研究与开发, 2020, 32(12):2031-2039. DOI: 10.16333/j.1001-6880.2020.12.007. doi: 10.16333/j.1001-6880.2020.12.007
[9]	李赛男. 传统中药罗布麻花、玫瑰花中黄酮类化合物的分离提取及活性评价研究[D]. 长春: 长春师范学院, 2012.
[10]	寇兴然, 朱松, 马朝阳, 等. 植物多酚生物利用度及提高方法研究进展[J]. 食品与生物技术学报, 2017, 36(1):1-7.
[11]	杨虎, 张生堂, 高国强. 玫瑰黄酮的提取及其清除DPPH自由基活性研究[J]. 食品科学, 2012, 33(24):152-155.
[12]	RINWA P, KUMAR A. Quercetin suppress microglial neuroinflammatory response and induce antidepressent-like effect in olfactory bulbectomized rats[J]. Neuroscience, 2013, 255:86-98. DOI: 10.1016/j.neuroscience.2013.09.044. doi: 10.1016/j.neuroscience.2013.09.044
[13]	MACHADO D G, BETTIO L E B, CUNHA M P, et al. Antidepressant-like effect of rutin isolated from the ethanolic extract from Schinus molle L. in mice:evidence for the involvement of the serotonergic and noradrenergic systems[J]. European Journal of Pharmacology, 2008, 587(1/2/3):163-168. DOI: 10.1016/j.ejphar.2008.03.021. doi: 10.1016/j.ejphar.2008.03.021
[14]	韩亚琼, 李涛, 谷争, 等. 红景天苷对抑郁模型大鼠炎症反应和神经细胞凋亡的抑制作用及其机制[J]. 医药导报, 2021, 40(5):598-605. DOI: 10.3870/j.issn.1004-0781.2021.05.005. doi: 10.3870/j.issn.1004-0781.2021.05.005
[15]	王苗苗, 刘宗浩, 张永, 等. 2种新疆沙棘中黄酮、多酚及其抗氧化活性分析[J]. 食品工业科技, 2020, 41(18):51-57. DOI: 10.13386/j.issn1002-0306.2020.18.008. doi: 10.13386/j.issn1002-0306.2020.18.008
[16]	张彦, 祝晨蔯. 金丝桃苷对慢性不可预知温和刺激大鼠抑郁行为的影响[J]. 中国新药与临床杂志, 2017, 36(3):150-156. DOI: 10.14109/j.cnki.xyylc.2017.03.007. doi: 10.14109/j.cnki.xyylc.2017.03.007
[17]	李丽梅, 娄洁, 刘贵有, 等. 玫瑰花中的异黄酮类化合物及其活性研究[J]. 中草药, 2015, 46(10):1420-1422.
[18]	DUMAN R S, VOLETI B. Signaling pathways underlying the pathophysiology and treatment of depression:novel mechanisms for rapid-acting agents[J]. Trends in Neurosciences, 2012, 35(1):47-56. DOI: 10.1016/j.tins.2011.11.004. doi: 10.1016/j.tins.2011.11.004
[19]	易志凯, 杨杰, 李娜. 氟西汀对抑郁大鼠海马血管新生因子表达的影响[J]. 中华行为医学与脑科学杂志, 2018, 27(3):235-240. DOI: 10.3760/cma.j.issn.1674-6554.2018.03.010. doi: 10.3760/cma.j.issn.1674-6554.2018.03.010
[20]	LI G F, ZHAO M, CHENG X, et al. FG-4592 improves depressive-like behaviors through HIF-1-mediated neurogenesis and synapse plasticity in rats[J]. Neurotherapeutics, 2020, 17(2):664-675. DOI: 10.1007/s13311-019-00807-3. doi: 10.1007/s13311-019-00807-3
[21]	TIAN R H, BAI Y, LI J Y, et al. Reducing PRLR expression and JAK2 activity results in an increase in BDNF expression and inhibits the apoptosis of CA3 hippocampal neurons in a chronic mild stress model of depression[J]. Brain Research, 2019, 1725:146472. DOI: 10.1016/j.brainres.2019.146472. doi: 10.1016/j.brainres.2019.146472
[22]	MAES M, YIRMYIA R, NORABERG J, et al. The inflammatory & neurodegenerative(I&ND) hypothesis of depression:Leads for future research and new drug developments in depression[J]. Metabolic Brain Disease, 2009, 24(1):27-53. DOI: 10.1007/s11011-008-9118-1. doi: 10.1007/s11011-008-9118-1
[23]	MINGHETTI L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases[J]. Journal of Neuropathology and Experimental Neurology, 2004, 63(9):901-910. DOI: 10.1093/jnen/63.9.901. doi: 10.1093/jnen/63.9.901
[24]	AKTAN F. iNOS-mediated nitric oxide production and its regulation[J]. Life Sciences, 2004, 75(6):639-653. DOI: 10.1016/j.lfs.2003.10.042. doi: 10.1016/j.lfs.2003.10.042
[25]	MÜLLER N, SCHWARZ M J. The immune-mediated alteration of serotonin and glutamate:towards an integrated view of depression[J]. Molecular Psychiatry, 2007, 12(11):988-1000. DOI: 10.1038/sj.mp.4002006. doi: 10.1038/sj.mp.4002006
[26]	RYAN J, SCALI J, CARRIÈRe I, et al. Estrogen receptor alpha gene variants and major depressive episodes[J]. Journal of Affective Disorders, 2012, 136(3):1222-1226.DOI: 10.1016/j.jad.2011.10.010. doi: 10.1016/j.jad.2011.10.010
[27]	LIMÓN-MORALES O, ARTEAGA-SILVA M, ROJAS-CASTAÑEDA J C, et al. Neonatal treatment with clomipramine modifies the expression of estrogen receptors in brain areas of male adult rats[J]. Brain Research, 2019, 1724:146443.DOI: 10.1016/j.brainres.2019.146443. doi: 10.1016/j.brainres.2019.146443

分类代码	化合物分类	成分名称
		矢车菊素-3,5-二葡萄糖苷
C1	黄酮类	矢车菊素-3-槐糖苷-5-葡萄糖苷
		芹菜素-7- O -葡萄糖苷
C2	萜类	(+)-柠檬烯
		β-胡萝卜素
		异丁香酚
C3	苯丙素类	甲基丁香酚
		没食子酸
C4	甾体类	西托糖苷
		花梗鞣素
C5	酚酸类	1,2,3-三-O-没食子酰-β-D-葡萄糖
		皱褶菌素E

序号	通用蛋白质编号	蛋白名称	棕榈数据编号	成分编号	成分中文名	成分英文名	度值	打分值
				MOL000008	芹菜素	Apigenin		31.932 5
1	P31749	AKT1	4EJN	MOL000098	槲皮素	Quercetin	20	39.637 5
				MOL000422	山柰酚	Kaempferol		32.829 6
				MOL000008	芹菜素	Apigenin		30.874 0
				MOL000206	异丁香酚	Isoeugenol		14.820 4
2	P35354	PTGS2	5IKV	MOL000422	山柰酚	Kaempferol	19	30.300 6
				MOL000437	异槲皮苷	Hirsutrin		-3.046 7
				MOL004799	矢车菊素-3-O-葡萄糖苷	Cyanidin 3-O-glucoside		-7.491 9
				MOL000008	芹菜素	Apigenin		34.453 2
3	P03372	ESR1	6PET	MOL000206	异丁香酚	Isoeugenol	18	15.007 3
				MOL000422	山柰酚	Kaempferol		36.847 6

The basis and mechanism of Rosae Rugosae Flos antidepressants based on network pharmacology

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 13

References 27

Related Articles 15

Metrics

Comments

Recommended 0

[1]	SUN Jingtian, LIU Feng, ZHANG Zhe, ZHANG Yufu, MA Xinhui, LI Qingjun, WANG Xiao, DONG Hongjing. Exploring the medication rule of Chrysanthemum morifolium Ramat. and investigating the synergistic pharmacological activity of core combination herbs [J]. Shandong Science, 2025, 38(1): 1-8.
[2]	HAN Huijie, LIU Hui, ZHAO Yongbo, WANG Songpo. A study based on network pharmacology and experimental verification exploring the mechanism of quercetin against colorectal cancer through the p53 signaling pathway [J]. Shandong Science, 2025, 38(1): 32-43.
[3]	FAN Wei, SHEN Chuanlin, ZHANG Xuanming, DU Xingshuo, ZHAN Wen, SUN Chen, JIN Meng, LI Xiaobin, ZHANG Sichen, SUN Botong, HE Qiuxia. Prediction of anti-aging mechanism of Panax quinquefolius L. by network pharmacology and molecular docking [J]. Shandong Science, 2024, 37(6): 42-50.
[4]	YAN Jin, LI Fei, WU Keming, YANG Haobo. The molecular mechanisms by which Xinjia Cistanche Tusi Decoction promotes follicular development through mitophagy [J]. Shandong Science, 2024, 37(5): 25-34.
[5]	LIN Shenghua, XUE Chang, MA honglin, FAN Wei, SHEN Chuanlin, CHEN Jiayu, SUN Botong, DU Xingshuo, ZHAN Wen, LI Xiaobin, ZHANG Shanshan, JIN Meng, HE Qiuxia. Study of the active components and mechanism of action of antithrombotic Xuefuzhuyu oral liquid based on network pharmacology and molecular docking technology [J]. Shandong Science, 2024, 37(4): 26-33.
[6]	MA Shijing, HE Chunyan, GUAN Tianzhu, YAO Xueshuang, ZHANG Junpeng. Exploration of antihyperlipidemia mechanism of Monopterus albus peptides based on hyperlipidemic zebrafish model and network pharmacology [J]. Shandong Science, 2024, 37(3): 27-38.
[7]	WEI Zekun, YANG Yujie, LIU Shuang, WANG Yan, DONG Hongjing, LIU Chunmei. Reverse mining of Chinese medicine for intervention of liver cancer based on GEO database combined with network pharmacology and molecular docking technology [J]. Shandong Science, 2024, 37(3): 39-47.
[8]	LIU Kechun, WANG Yongcheng, ZANG Xiaohan, XIA Qing, ZHANG Yun, ZHANG Shanshan, SUN Chen. Advancements in network pharmacology and zebrafish modeling for studying traditional Chinese medicine’s effective substances and mechanisms of action [J]. Shandong Science, 2024, 37(2): 29-35.
[9]	FU Zhaoju, CHENG Guo, LIN Dengmei, LI Jun, ZHANG Nannan. Experimental study and network pharmacological analysis of the anti-inflammatory action mechanism of Mahonia bealei (Fort.) Carr. [J]. Shandong Science, 2024, 37(1): 24-31.
[10]	CHEN Chun, QI Daqing, PAN Jingwen. Clinical significance of stromal cell score in gastric cancer and intervention with Weifuchun capsules [J]. Shandong Science, 2023, 36(6): 38-47.
[11]	MU Nana, LIAO Binbin, LI Zhen, LI Jipin, LI Yihua, WANG Ying, CHEN Xubing. Investigating the mechanism of action of Elephantopus scaber L. in the treatment of ulcerative colitis based on network pharmacology and molecular docking [J]. Shandong Science, 2023, 36(6): 48-55.
[12]	WANG Yifan, ZHANG Zhe, TIAN Caijun. Mechanism of Sanhuang Xiexin decoction in treatment of Alzheimer's disease based on network pharmacology and molecular docking method [J]. Shandong Science, 2023, 36(5): 19-26.
[13]	FU Mengya, AO Huihao, BU Chao, PENG Tangyi, WU Deling, HAN Yanquan, HONG Yan. Forecast analysis of the quality markers of Zingiberis Rhizoma based on fingerprints and network pharmacology [J]. Shandong Science, 2023, 36(4): 35-41.
[14]	YIN Zhipeng, GAO Yunyun, LIU Wenwen, GUO Pengbo, ZHAO Yinghui. Exploring the mechanism of Xiangsha Liujunzi Decoction in treating Helicobacter pylori-associated gastritis based on network pharmacology and molecular docking technology [J]. Shandong Science, 2023, 36(4): 52-60.
[15]	SUN Tiefeng, DONG Limin, JIAO Ziqi, WANG Ping. Exploration of the dosing pattern and anti-respiratory syncytial virus mechanism of traditional Chinese medicine based on data mining and network pharmacology [J]. Shandong Science, 2023, 36(3): 1-9.